Comparative morphology at a crossroads
American Journal of Botany · 2024
DOI: 10.1002/ajb2.16392 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Botany, 2024. Verfasst von Julius Jeiter und 1 weiteren Autor:innen. Beteiligte Einrichtung: Chair of Botany, Faculty of Biology, TUD Dresden University of Technology, Dresden, 01062, Germany. Hauptthemen laut MEDLINE: Biological Evolution. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Morphology has been the fundamental and most important source of information in biology. We strongly believe that in the current molecular era of biology, comparative morphology still has an important role to play in understanding life on Earth and ecosystem functioning, bridging the knowledge gap between evolution, systematics, and ecology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chair of Botany, Faculty of Biology, TUD Dresden University of Technology, Dresden, 01062, Germany.
- Nees Institute for Biodiversity of Plants, University of Bonn, Meckenheimer Allee 170, Bonn, 53115, Germany.
- Naturalis Biodiversity Center, Darwinweg 2, 2333 CR Leiden, Leiden, The Netherlands.
- Institute of Biology Leiden, Leiden University, Sylviusweg 72, Leiden, 2333 BE, The Netherlands.
- Ecology, Evolution and Biodiversity Conservation, KU Leuven, Kasteelpark Arenberg 31, Box 2435, Heverlee, 3001, Belgium.
ORCID-Profile: Julius Jeiter, Erik Smets
Zitieren
APA
Jeiter, J., & Smets, E. (2024). Comparative morphology at a crossroads. American Journal of Botany. https://doi.org/10.1002/ajb2.16392
Vancouver
Jeiter J, Smets E. Comparative morphology at a crossroads. American Journal of Botany. 2024. doi:10.1002/ajb2.16392
BibTeX
@article{Jeiter2024,
author = {Jeiter, Julius and Smets, Erik},
title = {Comparative morphology at a crossroads},
journal = {American Journal of Botany},
year = {2024},
doi = {10.1002/ajb2.16392}
}
EUVIMED